Soleimani VD, Rudnicki MA (2011) New insights into the origin and the genetic basis of rhabdomyosarcomas. Cancer Cell 19:157. https://doi.org/10.1016/J.CCR.2011.01.044
Article CAS PubMed PubMed Central Google Scholar
Frederick P, Li JFF (1969) Rhabdomyosarcoma in children: epidemiologic study and identification of a familial caneer syndrome. JNCI: J Natl Cancer Inst. https://doi.org/10.1093/jnci/43.6.1365
Li H, Sisoudiya SD, Martin-Giacalone BA et al (2021) Germline cancer predisposition variants in pediatric rhabdomyosarcoma: a report from the children’s oncology group. J Natl Cancer Inst 113:875–883. https://doi.org/10.1093/JNCI/DJAA204
Rudzinski ER, Anderson JR, Hawkins DS et al (2015) The world health organization classification of skeletal muscle tumors in pediatric rhabdomyosarcoma: a report from the children’s oncology group. Arch Pathol Lab Med 139:1281–1287. https://doi.org/10.5858/ARPA.2014-0475-OA
Article PubMed PubMed Central Google Scholar
Linet MS, Ries LAG, Smith MA et al (1999) Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst 91:1051–1058. https://doi.org/10.1093/JNCI/91.12.1051
Article CAS PubMed Google Scholar
Crist W, Gehan EA, Ragab AH et al (1995) The third intergroup rhabdomyosarcoma study. J Clin Oncol 13:610–630. https://doi.org/10.1200/JCO.1995.13.3.610
Article CAS PubMed Google Scholar
Jurdy L, Merks JHM, Pieters BR et al (2013) Orbital rhabdomyosarcomas: a review. Saudi J Ophthalmol 27:167–175. https://doi.org/10.1016/J.SJOPT.2013.06.004
Article PubMed PubMed Central Google Scholar
Sultan I, Qaddoumi I, Yaser S et al (2009) Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. J Clin Oncol 27:3391–3397. https://doi.org/10.1200/JCO.2008.19.7483
Hassan WM, Alfaar AS, Bakry MS, Ezzat S (2014) Orbital tumors in USA: difference in survival patterns. Cancer Epidemiol 38:515–522. https://doi.org/10.1016/J.CANEP.2014.07.001
Ward ZJ, Yeh JM, Bhakta N et al (2019) Estimating the total incidence of global childhood cancer: a simulation-based analysis. Lancet Oncol 20:483–493. https://doi.org/10.1016/S1470-2045(18)30909-4
Raney Jr RB (1981) Special considerations related to primary site in rhabdomyosarcoma: experience of the intergroup rhabdomyosarcoma study, 1972–76 - PubMed. Natl Cancer Inst Monogr 56:69–74
Metts J, Xue W, Gao Z et al (2023) Survival of patients with orbital and eyelid rhabdomyosarcoma treated on children’s oncology group studies from 1997 to 2013: a report from the children’s oncology Group. Cancer 129:1735–1743. https://doi.org/10.1002/cncr.34723
Tang LY, Zhang MX, Lu DH et al (2018) The prognosis and effects of local treatment strategies for orbital embryonal rhabdomyosarcoma: a population-based study. Cancer Manag Res 10:1727–1734. https://doi.org/10.2147/CMAR.S163932
Article PubMed PubMed Central Google Scholar
Fay MP, Tiwari RC, Feuer EJ, Zou Z (2006) Estimating average annual percent change for disease rates without assuming constant change. Biometrics 62:847–854. https://doi.org/10.1111/j.1541-0420.2006.00528.x
Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335–351. https://doi.org/10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z
Article CAS PubMed Google Scholar
Cho H, Howlader N, Mariotto AB, Cronin KA (2011) Estimating relative survival for cancer patients from the SEER Program using expected rates based on Ederer I versus Ederer II method. Washington DC. https://surveillance.cancer.gov/reports/tech2011.01.pdf
Brown CC (1983) The statistical comparison of relative survival rates. Biometrics 39:941. https://doi.org/10.2307/2531329
Article CAS PubMed Google Scholar
Bethesda M (2022) NCI. Surveillance research program, National Cancer Institute SEER*Stat software version 8.4.0.1 [Internet]. In: National Cancer Institute. https://seer.cancer.gov/seerstat. Accessed 7 May 2023
Kim H-J, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates - PubMed. Stat Med 19:335–351. https://doi.org/10.1002/(sici)1097-0258(20000215)19:3%3c335::aid-sim336%3e3.0.co;2-z
Statistical Research and Applications, Branch NCI (2022) Joinpoint regression program. https://surveillance.cancer.gov/joinpoint/. Accessed 7 May 2023
Yu B, Huang L, Tiwari RC et al (2009) Modelling population-based cancer survival trends using join point models for grouped survival data. J R Stat Soc Ser Stat Soc 172:405. https://doi.org/10.1111/J.1467-985X.2009.00580.X
Turner JH, Richmon JD (2011) Head and neck rhabdomyosarcoma: a critical analysis of population-based incidence and survival data. Otolaryngol Head Neck Surg 145:967–973. https://doi.org/10.1177/0194599811417063
Wyatt KD, Birz S, Hawkins DS et al (2022) Creating a data commons: the INternational soft tissue SaRcoma ConsorTium (INSTRuCT). Pediatr Blood Cancer 69. https://doi.org/10.1002/pbc.29924
Bray F, Parkin DM (2009) Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer 45:747–755. https://doi.org/10.1016/j.ejca.2008.11.032
Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492
Singh V, Saini V, Ora M, Gambhir S (2024) Paranasal sinus embryonal rhabdomyosarcoma metastasizing to breast and ovary on PET/CT—a case report with the review of literature. Indian J Med Pediatr Oncol 45:454–458. https://doi.org/10.1055/s-0043-1768179
Martin-Giacalone BA, Weinstein PA, Plon SE, Lupo PJ (2021) Pediatric rhabdomyosarcoma: epidemiology and genetic susceptibility. J Clin Med 10:2028. https://doi.org/10.3390/jcm10092028
Article PubMed PubMed Central Google Scholar
Ognjanovic S, Linabery AM, Charbonneau B, Ross JA (2009) Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975–2005. Cancer 115:4218–4226. https://doi.org/10.1002/cncr.24465
de Vries ISA, van Ewijk R, Adriaansen LME et al (2023) Imaging in rhabdomyosarcoma: a patient journey. Pediatr Radiol 53:788–812. https://doi.org/10.1007/s00247-023-05596-8
Article PubMed PubMed Central Google Scholar
Freling NJM, Merks JHM, Saeed P et al (2010) Imaging findings in craniofacial childhood rhabdomyosarcoma. Pediatr Radiol 40:1723–1738. https://doi.org/10.1007/S00247-010-1787-3
Article PubMed PubMed Central Google Scholar
Zhen H, Liu Z, Guan H et al (2021) Second malignant neoplasms in patients with rhabdomyosarcoma. Front Oncol 11. https://doi.org/10.3389/FONC.2021.757095.
Oberlin O, Rey A, Anderson J et al (2001) Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment–results of an international workshop. J Clin Oncol 19:197–204. https://doi.org/10.1200/JCO.2001.19.1.197
Article CAS PubMed Google Scholar
Chen C, Dorado Garcia H, Scheer M, Henssen AG (2019) Current and future treatment strategies for rhabdomyosarcoma. Front Oncol 9. https://doi.org/10.3389/fonc.2019.01458
Proudfit A, Bhunia N, Pore D et al (2020) Pharmacologic inhibition of Ezrin-Radixin-Moesin phosphorylation is a novel therapeutic strategy in rhabdomyosarcoma. Sarcoma 2020:1–11. https://doi.org/10.1155/2020/9010496
Shern JF, Selfe J, Izquierdo E et al (2021) Genomic classification and clinical outcome in rhabdomyosarcoma: a report from an international consortium. J Clin Oncol 39:2859–2871. https://doi.org/10.1200/JCO.20.03060
Article CAS PubMed PubMed Central Google Scholar
Hiniker SM, Donaldson SS (2015) Recent advances in understanding and managing rhabdomyosarcoma. F1000Prime Rep 7. https://doi.org/10.12703/P7-59.
Staibano S, Franco R, Tranfa F et al (2004) Orbital rhabdomyosarcoma: relationship between DNA ploidy, p53, bcl-2, MDR-1 and Ki67 (MIB1) expression and clinical behavior. Anticancer Res 24:249–257
留言 (0)